Literature DB >> 29157620

Unicentric Castleman Disease.

Raymond S M Wong1.   

Abstract

Unicentric Castleman disease (UCD) is a rare lymphoproliferative disorder that manifests typically as proliferation of a single lymph node or region of lymph nodes. Histologically, hyaline vascular variant is found in a majority of UCDs. UCD commonly presents in younger patient populations. Patients with UCD may be asymptomatic or present with symptoms related to mass effects on surrounding structures. It is difficult to achieve a definitive diagnosis by imaging alone. Histologic examination of the lesion remains the gold standard for diagnosis. Complete surgical resection is the best primary treatment modality for UCD resulting in excellent long-term survival and low recurrence rates.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Castleman disease; Hyaline vascular variant; Interleukin 6; Plasma cell variant; Unicentric

Mesh:

Year:  2018        PMID: 29157620     DOI: 10.1016/j.hoc.2017.09.006

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  17 in total

1.  A mesorectal incidentaloma: Rare localization of Castleman disease (Case report).

Authors:  Daniel Ion; Alexandra Bolocan; Alexandru George Filipescu; Octavian Andronic; Ana-Maria Oproiu; Adelina Popa; Dan Nicoale Păduraru
Journal:  Exp Ther Med       Date:  2022-02-08       Impact factor: 2.447

2.  18F-FDG PET/CT in lung B lymphoid hyperplasia-type Castleman disease.

Authors:  Paula Fernández-Rodríguez; Rosa Fernández López; Irene Acevedo Báñez; Javier Mohigefer Barrera; José Manuel Jiménez-Hoyuela García
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-07       Impact factor: 9.236

3.  Histologic and Laboratory Characteristics of Symptomatic and Asymptomatic Castleman Disease in the Pediatric Population.

Authors:  Karen M Chisholm; Mark D Fleming
Journal:  Am J Clin Pathol       Date:  2020-05-05       Impact factor: 2.493

Review 4.  Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review.

Authors:  Małgorzata Wojtyś; Agnieszka Piekarska; Michał Kunc; Konrad Ptaszyński; Wojciech Biernat; Jan Maciej Zaucha; Piotr Waloszczyk; Piotr Lisowski; Bartosz Kubisa; Tomasz Grodzki
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

5.  Iron-Refractory Iron Deficiency Anemia in an 11-year-old Girl.

Authors:  Neeraja Swaminathan; Scott M Lieberman; Sharathkumar Bhagavathi; Anjali Sharathkumar
Journal:  Pediatr Rev       Date:  2021-07

6.  International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.

Authors:  Frits van Rhee; Eric Oksenhendler; Gordan Srkalovic; Peter Voorhees; Megan Lim; Angela Dispenzieri; Makoto Ide; Sophia Parente; Stephen Schey; Matthew Streetly; Raymond Wong; David Wu; Ivan Maillard; Joshua Brandstadter; Nikhil Munshi; Wilbur Bowne; Kojo S Elenitoba-Johnson; Alexander Fössa; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Sheila K Pierson; Amy Greenway; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Amy Chadburn; David C Fajgenbaum
Journal:  Blood Adv       Date:  2020-12-08

7.  Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.

Authors:  Yi Zhang; Shan-Shan Suo; Han-Jin Yang; Xin-Ping Zhou; Liang-Shun You; Wen-Juan Yu; Zhao-Ming Wang; Jie Jin
Journal:  J Cancer Res Clin Oncol       Date:  2020-01-14       Impact factor: 4.553

8.  A 10-year observational single-center study of retroperitoneal unicentric Castleman disease.

Authors:  Wenda Wang; Dexin Dong; Jin Wen; Hanzhong Li
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

9.  Unicentric Castleman Disease and Pheochromocytoma.

Authors:  Rosana Maia; Joana Couto; José Diogo; Edgar Torre; Diana Guerra
Journal:  Eur J Case Rep Intern Med       Date:  2022-01-14

10.  Castleman disease. Interaction with dermatopathy: Case report.

Authors:  M L A Modolin; C P Camargo; D A Milcheski; W Cintra; R I Rocha; G M Clivatti; B Nascimento; R Gemperli
Journal:  Int J Surg Case Rep       Date:  2020-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.